Global Biosimilars Market which is valued close to $18 billion (2020) is growing at a Double-Digit Rate

A biosimilar is a biological product which is similar to a reference biologic with no clinically meaningful differences in terms of potency, purity, and safety.

Loss of patent protection for originator brands to drive the biosimilar market growth

A key driver of biosimilar market growth over the next 5-10 years is the number of losses of protection (LoP) events for originator brands. In the US alone, 66 biologic U.S. patents are expiring between 2020 and 2025, owing to which the biosimilar market is on the cusp of a significant boost. Oncology is one of the major therapeutic areas in biosimilars market and by 2023, patents on nearly 20 oncology biologics will expire, which could lead to more biosimilars to enter in oncology space and propelling oncology biosimilars market.

Consistent growth in the biosimilar approvals in the US biosimilars market

The US biosimilars market is growing across multiple therapeutic areas. From 1 approval in 2015, the number of FDA approvals have increased to 10 in 2019 (only 3 approvals in 2020 impacted by COVID as shown in figure below). The steady and consistent increase in number of biosimilar approvals and market availability in US is driving the US biosimilars market growth. In 2015, only 1 biosimilar product was available for use in market and this number reached to 19 by end of 2020.

“There is a huge growth potential for biosimilar market as they deliver significant benefits to the healthcare community. Biosimilars help augment overall treatment options, positively impact patients suffering from life-threatening conditions, whilst contributing to the quality and financial sustainability of healthcare systems.” – CEO, Leading Biosimilars Company

Regional Snapshot: Global Biosimilars Market

Europe is the largest market for biosimilars owing to adoption of more liberal policies which has enabled greater market access. Whereas, United States has taken a more protective approach towards originator brands, further influenced by lobbying from pharma companies. Owing to this, the biosimilar adoption is relatively slower in US. However, the US biosimilar landscape is now evolving rapidly. There were 29 biosimilars approved in US compared to 11 in EU in the initial six years. Also, in April 2021, the US signed two bipartisan bills to reduce prescription drug prices by supporting generics/biosimilars. Such developments will fuel the growth of the US biosimilars market.

The key players working in the global biosimilars market are Amgen, Roche, Sandoz, Dr. Reddy’s, Teva, Pfizer, Eli Lilly, Samsung, Biocon, Boehringer, and Mylan.

Explore Detailed Insights on Global Biosimilars Market @ https://meditechinsights.com/global-biosimilars-market/

Comments

Post a Comment

Popular posts from this blog

Global HPV Testing and PAP Test Market is slated to grow at a lucrative CAGR of 12 to 15 % by 2027 – Growing Revolution for the Prevention of Cervical Cancer

Cervical cancer is a malignant tumor which starts in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transforms into precancerous cells. If not destroyed, these abnormal cells may turn into harmful cancer cells and spread in the cervix and surrounding areas. Cervical cancer screening involves HPV and PAP tests , which can identify HPV infection or pre-cancerous lesions at an early stage and if correct treatment is offered at the right time then the cancer can be prevented. Impact of  Covid-19 on  the Global HPV Testing and PAP Test Market Covid-19 pandemic had impacted the healthcare market in many ways. During Covid pandemic, due to strict social-distancing norms in hospitals, there was a delay in many diagnostic examinations and procedures. The delay in the cancer screening services due to the lack of skilled healthcare staff and disruption in the supply chain of testing kits across the world had led to a severe impact o
Read more

Global Medical Display Market is projected to witness a CAGR of 5% by 2027 - Transforming Medical Imaging

Medical displays are purpose-built solutions which offer quick improvements in viewing angle, longevity, luminance, and noise reduction to assure substantially superior accuracy and effectiveness of medical images. Technological Developments and Innovations in Medical Display Drives the Growth of the Global Medical Display Market With the rapid innovations and developments in medical technology, many high-end medical equipment's are being introduced in the global market. Flat-panel displays, holograms, and head-mounted displays are quickly changing the manner in which medical messages are being communicated. The majority of displays used for medical imaging are liquid crystal displays (LCDs) backlit with either CCFLs or LEDs.  For instance,  In January 2023, Barco announced the release of a new LED solution which completes its next-generation LED portfolio. Adoption of Multimodality Display Fuels the Global Growth of the Medical Display Market  With the fast evolution of the medi
Read more

Global Ambulatory Surgical Center (ASC) Software Market is Poised to Grow at a CAGR of 10% by 2027

Ambulatory Surgical Care is a medical care offered in the outpatient setting and does not need any hospital admission. Ambulatory Surgical Center or ASCs—are health care facilities focused on offering same-day surgical care, including diagnostic and preventive procedures. ASCs have transformed the outpatient experience by offering a convenient alternative to hospital-based outpatient procedures. Common procedures performed in ASCs are cataract surgery, gallbladder removal, tonsillectomy, endoscopy, colonoscopy, arthroscopic or orthopedic procedures, and cardiac procedures. Owing to their various cost benefits and convenience, the volume of procedures performed at ASCs is rising and ASC software is likely to play a major role in these settings by easing the day to day operations by preparing staff and patients for pre-op and post-op tasks. Rising Investments in Ambulatory Surgical Center  from Healthcare Companies Shows a Huge Growth Potential for Ambulatory Surgical Center Software Ma
Read more